{"hands_on_practices": [{"introduction": "The initiation of many immune signaling cascades relies on the enzymatic transfer of ubiquitin to a target substrate, a reaction catalyzed by an E3 ubiquitin ligase. Understanding the speed of this \"writing\" process is fundamental to quantifying signal activation. This practice applies the classic Michaelis-Menten model to the ubiquitin conjugation machinery, allowing you to calculate the initial rate of signal generation based on enzyme and substrate concentrations and the intrinsic catalytic properties of the ligase, such as its turnover number ($k_{\\text{cat}}$) and Michaelis constant ($K_M$) [@problem_id:2905228].", "problem": "A receptor-proximal ubiquitin ligase complex that controls nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling catalyzes transfer of ubiquitin (Ub) from a ubiquitin-charged ubiquitin-conjugating enzyme (Ub∼E2) to a lysine on a bound substrate. Under standard biochemical conditions with saturating adenosine triphosphate (ATP) and ubiquitin such that charging of the ubiquitin-conjugating enzyme (E2) by the ubiquitin-activating enzyme (E1) is rapid, the conjugation step can be described by Michaelis–Menten kinetics with respect to the Ub∼E2 species as the variable substrate for the ubiquitin ligase (E3)–substrate complex. Assume that prior to initiating the conjugation reaction, the E2 pool has been pre-equilibrated under saturating ubiquitin such that essentially the entire E2 pool is in the charged Ub∼E2 state, and that the ubiquitin-activating enzyme (E1) is not rate-limiting for maintaining Ub∼E2 during the initial velocity measurement.\n\nYou are given:\n- Concentration of ubiquitin-activating enzyme (E1): $50\\,\\text{nM}$.\n- Concentration of ubiquitin-conjugating enzyme (E2): $1\\,\\mu\\text{M}$.\n- Concentration of the pre-assembled E3–substrate complex (treated as the enzyme for the conjugation step): $200\\,\\text{nM}$.\n- Turnover number for Ub transfer by the E3–substrate complex: $k_{\\text{cat}}=1.2\\,\\text{s}^{-1}$.\n- Michaelis constant with respect to Ub∼E2: $K_M=10\\,\\mu\\text{M}$.\n- Ubiquitin is saturating.\n\nUsing only foundational enzyme kinetics and the quasi–steady-state approximation, compute the initial rate of ubiquitin transfer to substrate, $v_0$, under these conditions. Express your final answer in $\\text{nM}\\,\\text{s}^{-1}$ and round your answer to three significant figures.", "solution": "The problem requires the calculation of an initial reaction rate, $v_0$, for an enzymatic reaction. This is a standard problem in chemical kinetics. The system is described as following the Michaelis-Menten model, which is derived under the quasi-steady-state approximation as stipulated.\n\nThe central equation for Michaelis-Menten kinetics is:\n$$v_0 = \\frac{V_{\\text{max}} [S]}{K_M + [S]}$$\nwhere $v_0$ is the initial velocity, $[S]$ is the substrate concentration, $K_M$ is the Michaelis constant, and $V_{\\text{max}}$ is the maximum velocity. The maximum velocity is related to the total enzyme concentration, $[E]_T$, and the turnover number, $k_{\\text{cat}}$, by the relation:\n$$V_{\\text{max}} = k_{\\text{cat}} [E]_T$$\nSubstituting this into the primary equation gives the full expression for the initial velocity:\n$$v_0 = \\frac{k_{\\text{cat}} [E]_T [S]}{K_M + [S]}$$\nThe problem provides all necessary parameters, though it is necessary to correctly identify which component corresponds to the enzyme and which to the substrate in the context of the specific reaction step being analyzed.\n\nThe reaction step under consideration is the transfer of ubiquitin from the charged ubiquitin-conjugating enzyme ($\\text{Ub}\\sim\\text{E2}$) to a substrate molecule bound by the ubiquitin ligase ($E3$).\nTherefore, for this kinetic analysis:\n- The \"enzyme\" is the pre-assembled $E3$–substrate complex. Its total concentration is given as $[E]_T = 200\\,\\text{nM}$.\n- The \"substrate\" is the ubiquitin-charged conjugating enzyme, $\\text{Ub}\\sim\\text{E2}$. The problem states that the entire $E2$ pool, with a total concentration of $1\\,\\mu\\text{M}$, is in this charged state. Thus, the substrate concentration is $[S] = 1\\,\\mu\\text{M}$.\n\nThe other provided parameters are:\n- The turnover number, $k_{\\text{cat}} = 1.2\\,\\text{s}^{-1}$.\n- The Michaelis constant, $K_M = 10\\,\\mu\\text{M}$.\n\nThe concentration of the ubiquitin-activating enzyme ($E1$) of $50\\,\\text{nM}$ is extraneous information, as the problem specifies that the E1-dependent charging step is rapid and not rate-limiting for the initial velocity measurement.\n\nBefore calculation, all concentrations must be in consistent units. We will convert all concentrations to micromolar ($\\mu\\text{M}$).\n- Total enzyme concentration: $[E]_T = 200\\,\\text{nM} = 0.2\\,\\mu\\text{M}$.\n- Substrate concentration: $[S] = 1\\,\\mu\\text{M}$.\n- Michaelis constant: $K_M = 10\\,\\mu\\text{M}$.\n\nWe can now substitute these values into the Michaelis-Menten equation:\n$$v_0 = \\frac{(1.2\\,\\text{s}^{-1}) \\cdot (0.2\\,\\mu\\text{M}) \\cdot (1\\,\\mu\\text{M})}{10\\,\\mu\\text{M} + 1\\,\\mu\\text{M}}$$\nPerforming the calculation for the numerator and denominator separately:\nNumerator: $(1.2\\,\\text{s}^{-1}) \\cdot (0.2\\,\\mu\\text{M}) \\cdot (1\\,\\mu\\text{M}) = 0.24\\,\\mu\\text{M}^2 \\cdot \\text{s}^{-1}$.\nDenominator: $10\\,\\mu\\text{M} + 1\\,\\mu\\text{M} = 11\\,\\mu\\text{M}$.\nDividing the numerator by the denominator:\n$$v_0 = \\frac{0.24\\,\\mu\\text{M}^2 \\cdot \\text{s}^{-1}}{11\\,\\mu\\text{M}} = \\frac{0.24}{11}\\,\\mu\\text{M} \\cdot \\text{s}^{-1}$$\n$$v_0 \\approx 0.021818...\\,\\mu\\text{M} \\cdot \\text{s}^{-1}$$\nThe problem requests the final answer to be expressed in units of $\\text{nM}\\,\\text{s}^{-1}$. We convert the result:\n$$v_0 \\approx 0.021818...\\,\\mu\\text{M} \\cdot \\text{s}^{-1} \\times \\frac{1000\\,\\text{nM}}{1\\,\\mu\\text{M}}$$\n$$v_0 \\approx 21.81818...\\,\\text{nM} \\cdot \\text{s}^{-1}$$\nFinally, we round the result to three significant figures as required.\n$$v_0 \\approx 21.8\\,\\text{nM} \\cdot \\text{s}^{-1}$$\nThis is the initial rate of ubiquitin transfer under the specified conditions.", "answer": "$$\\boxed{21.8}$$", "id": "2905228"}, {"introduction": "The duration and intensity of a signal are often controlled by the stability of key regulatory proteins. In the canonical NF-$\\kappa$B pathway, the degradation of the inhibitor $I\\kappa B\\alpha$ is a critical control point. This exercise explores the concept of protein half-life through the lens of first-order decay kinetics, providing a quantitative link between a molecular defect in substrate recognition by an E3 ligase and the resulting change in protein stability [@problem_id:2905177]. Mastering this connection is essential for predicting how mutations can alter signaling dynamics.", "problem": "In the canonical Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-$\\kappa$B) pathway, Inhibitor of kappa B alpha ($I\\kappa B\\alpha$) is targeted for degradation by the Skp1-Cullin-F-box (SCF) ubiquitin ligase complex containing Beta-transducin repeat-containing protein ($\\beta$TrCP) as the substrate-recognition subunit after phosphorylation of its phosphodegron. Consider a phosphodegron mutant of $I\\kappa B\\alpha$ that reduces $\\beta$TrCP recognition by a factor of $10$ while leaving all other steps (such as phosphorylation and proteasomal capacity) unchanged. Assume that, under these conditions, recognition by $\\beta$TrCP is the rate-limiting step and that the effective first-order degradation rate constant scales proportionally with recognition. In wild type cells, the effective first-order degradation rate constant is $k_{\\text{deg}} = 0.2\\,\\text{min}^{-1}$.\n\nStarting from the definition of first-order decay and the definition of half-life, derive the expression for the half-life in terms of the first-order rate constant and use it to compute the mutant half-life under the $10$-fold reduction in recognition. Express your final answer in minutes and round to four significant figures.", "solution": "The problem as stated is scientifically grounded, well-posed, and internally consistent. It describes a canonical biological process, the NF-$\\kappa$B signaling pathway, using a standard kinetic model, first-order decay. The parameters provided are physiologically reasonable. Therefore, the problem is valid, and we shall proceed with its formal solution.\n\nThe task requires us to first derive the relationship between the half-life and the rate constant for a first-order process, and then apply this to calculate the half-life of a mutant protein.\n\nLet $[C](t)$ represent the concentration of the protein $I\\kappa B\\alpha$ at time $t$. The degradation of this protein is described as a first-order process. The differential equation governing first-order decay is:\n$$ \\frac{d[C]}{dt} = -k [C] $$\nwhere $k$ is the first-order rate constant.\n\nTo find the concentration as a function of time, we must solve this ordinary differential equation. We can separate the variables:\n$$ \\frac{d[C]}{[C]} = -k \\, dt $$\nWe integrate this equation from an initial time $t=0$ with an initial concentration $[C]_0$ to an arbitrary time $t$ with concentration $[C](t)$:\n$$ \\int_{[C]_0}^{[C](t)} \\frac{d[c]}{c} = \\int_{0}^{t} -k \\, d\\tau $$\nThe integration yields:\n$$ \\ln([C](t)) - \\ln([C]_0) = -k(t-0) $$\n$$ \\ln\\left(\\frac{[C](t)}{[C]_0}\\right) = -kt $$\nBy exponentiating both sides, we obtain the integrated rate law for first-order decay:\n$$ [C](t) = [C]_0 \\exp(-kt) $$\nThe half-life, denoted $t_{1/2}$, is defined as the time at which the concentration $[C](t)$ falls to one-half of its initial value, $[C]_0$. So, at $t = t_{1/2}$, we have:\n$$ [C](t_{1/2}) = \\frac{1}{2} [C]_0 $$\nSubstituting this definition into the integrated rate law gives:\n$$ \\frac{1}{2} [C]_0 = [C]_0 \\exp(-k t_{1/2}) $$\nWe divide by $[C]_0$, which is presumed to be non-zero:\n$$ \\frac{1}{2} = \\exp(-k t_{1/2}) $$\nTo solve for $t_{1/2}$, we take the natural logarithm of both sides:\n$$ \\ln\\left(\\frac{1}{2}\\right) = -k t_{1/2} $$\nUsing the property of logarithms $\\ln(1/x) = -\\ln(x)$, we have:\n$$ -\\ln(2) = -k t_{1/2} $$\nThis simplifies to the fundamental relationship between the half-life and the rate constant for any first-order process:\n$$ t_{1/2} = \\frac{\\ln(2)}{k} $$\nThis completes the derivation part of the problem.\n\nNext, we apply this result to the specific case described. We are given the wild-type degradation rate constant, $k_{\\text{wt}} = 0.2\\,\\text{min}^{-1}$. We are also told that for the mutant $I\\kappa B\\alpha$, the recognition by $\\beta$TrCP is reduced by a factor of $10$. The problem states that this recognition step is rate-limiting and that the degradation rate constant $k$ scales proportionally with recognition.\n\nLet $R_{\\text{wt}}$ and $R_{\\text{mut}}$ be the recognition efficiencies for the wild-type and mutant proteins, respectively. According to the problem, $R_{\\text{mut}} = \\frac{1}{10} R_{\\text{wt}}$. Since the rate constant $k$ is proportional to the recognition efficiency $R$, we can write $k \\propto R$. This implies that the ratio of the rate constants is equal to the ratio of the recognition efficiencies:\n$$ \\frac{k_{\\text{mut}}}{k_{\\text{wt}}} = \\frac{R_{\\text{mut}}}{R_{\\text{wt}}} = \\frac{1}{10} $$\nWe can now calculate the rate constant for the mutant, $k_{\\text{mut}}$:\n$$ k_{\\text{mut}} = \\frac{1}{10} k_{\\text{wt}} = \\frac{1}{10} (0.2\\,\\text{min}^{-1}) = 0.02\\,\\text{min}^{-1} $$\nFinally, we compute the half-life of the mutant protein, $t_{1/2, \\text{mut}}$, using the derived formula:\n$$ t_{1/2, \\text{mut}} = \\frac{\\ln(2)}{k_{\\text{mut}}} = \\frac{\\ln(2)}{0.02\\,\\text{min}^{-1}} $$\nUsing the value $\\ln(2) \\approx 0.69314718$, we have:\n$$ t_{1/2, \\text{mut}} = \\frac{0.69314718}{0.02}\\,\\text{min} \\approx 34.657359\\,\\text{min} $$\nThe problem requires the answer to be rounded to four significant figures.\n$$ t_{1/2, \\text{mut}} \\approx 34.66\\,\\text{min} $$", "answer": "$$\\boxed{34.66}$$", "id": "2905177"}, {"introduction": "The \"ubiquitin code\" posits that different ubiquitin chain linkages elicit distinct cellular outcomes. This specificity is achieved by \"reader\" proteins that preferentially bind to one linkage type over another. This advanced problem models the molecular decision-making at the heart of signal decoding by analyzing a competitive binding equilibrium between two different tetraubiquitin chains (M1- and K63-linked) for a single binding domain [@problem_id:2905232]. By calculating the precise fraction of reader domains occupied by each ligand, you will gain a rigorous, quantitative understanding of how signaling specificity is maintained in a complex cellular environment.", "problem": "In receptor–ligand competition underlying ubiquitin linkage selectivity in immune signaling, consider the Ubiquitin Binding in A20-Binding Inhibitor of Nuclear factor kappa-B activation and NF-κB Essential Modulator (UBAN) motif, which binds both methionine-1 (M1)-linked linear tetraubiquitin and lysine-63 (K63)-linked tetraubiquitin. Assume a single, non-cooperative, $1{:}1$ binding site on UBAN for tetraubiquitin and that both linkage types compete for the same site. The dissociation constants are $K_{D,\\mathrm{M1}} = 100\\,\\mathrm{nM}$ and $K_{D,\\mathrm{K63}} = 1000\\,\\mathrm{nM}$. A well-mixed solution at equilibrium contains total UBAN concentration $R_{t} = 200\\,\\mathrm{nM}$ and total concentrations of each tetraubiquitin linkage $L_{t,\\mathrm{M1}} = 100\\,\\mathrm{nM}$ and $L_{t,\\mathrm{K63}} = 100\\,\\mathrm{nM}$. Proteasomal degradation is negligible on the timescale considered.\n\nStarting from the law of mass action and the definition of the dissociation constant, derive the equilibrium equations and compute the fractions of UBAN molecules bound by M1-linked and by K63-linked tetraubiquitin, respectively. Express both fractions as unitless decimals. Round your final numbers to four significant figures.\n\nReport your final result as a single row matrix $$\\begin{pmatrix} f_{\\mathrm{M1}} & f_{\\mathrm{K63}} \\end{pmatrix}$$, where $f_{\\mathrm{M1}}$ is the fraction of UBAN bound to M1-linked tetraubiquitin and $f_{\\mathrm{K63}}$ is the fraction bound to K63-linked tetraubiquitin.", "solution": "The problem describes a competitive binding equilibrium between a single receptor, UBAN, and two distinct ligands, M1-linked and K63-linked tetraubiquitin. The task is to compute the fraction of the receptor bound to each ligand at equilibrium. This requires a rigorous application of the law of mass action and the principle of mass conservation.\n\nFirst, we define the relevant species and their concentrations at equilibrium. Let $[R]$ be the concentration of free UBAN receptor. Let $[L_{\\mathrm{M1}}]$ and $[L_{\\mathrm{K63}}]$ be the concentrations of free M1-linked and K63-linked tetraubiquitin, respectively. Let $[C_{\\mathrm{M1}}]$ and $[C_{\\mathrm{K63}}]$ be the concentrations of the UBAN-M1 and UBAN-K63 complexes, respectively. The binding reactions are:\n$$R + L_{\\mathrm{M1}} \\rightleftharpoons C_{\\mathrm{M1}}$$\n$$R + L_{\\mathrm{K63}} \\rightleftharpoons C_{\\mathrm{K63}}$$\nThe dissociation constants for these reactions, $K_{D,\\mathrm{M1}}$ and $K_{D,\\mathrm{K63}}$, are given by the law of mass action:\n$$K_{D,\\mathrm{M1}} = \\frac{[R][L_{\\mathrm{M1}}]}{[C_{\\mathrm{M1}}]}$$\n$$K_{D,\\mathrm{K63}} = \\frac{[R][L_{\\mathrm{K63}}]}{[C_{\\mathrm{K63}}]}$$\nThe total concentrations of receptor and ligands are conserved. The mass balance equations are:\n$$R_t = [R] + [C_{\\mathrm{M1}}] + [C_{\\mathrm{K63}}]$$\n$$L_{t,\\mathrm{M1}} = [L_{\\mathrm{M1}}] + [C_{\\mathrm{M1}}]$$\n$$L_{t,\\mathrm{K63}} = [L_{\\mathrm{K63}}] + [C_{\\mathrm{K63}}]$$\nHere, the total concentrations are provided: $R_t = 200\\,\\mathrm{nM}$, $L_{t,\\mathrm{M1}} = 100\\,\\mathrm{nM}$, and $L_{t,\\mathrm{K63}} = 100\\,\\mathrm{nM}$. The dissociation constants are $K_{D,\\mathrm{M1}} = 100\\,\\mathrm{nM}$ and $K_{D,\\mathrm{K63}} = 1000\\,\\mathrm{nM}$.\n\nSince the total ligand concentrations are not significantly larger than the total receptor concentration, we cannot assume that the free ligand concentration is approximately equal to the total ligand concentration. Ligand depletion must be accounted for. We proceed by expressing all unknown concentrations in terms of a single variable, the free receptor concentration $[R]$.\n\nFrom the ligand mass balance equations, we express the free ligand concentrations:\n$$[L_{\\mathrm{M1}}] = L_{t,\\mathrm{M1}} - [C_{\\mathrm{M1}}]$$\n$$[L_{\\mathrm{K63}}] = L_{t,\\mathrm{K63}} - [C_{\\mathrm{K63}}]$$\nSubstitute these into the dissociation constant equations and solve for the complex concentrations:\n$$K_{D,\\mathrm{M1}} = \\frac{[R](L_{t,\\mathrm{M1}} - [C_{\\mathrm{M1}}])}{[C_{\\mathrm{M1}}]} \\implies [C_{\\mathrm{M1}}](K_{D,\\mathrm{M1}} + [R]) = [R]L_{t,\\mathrm{M1}}$$\n$$[C_{\\mathrm{M1}}] = \\frac{[R]L_{t,\\mathrm{M1}}}{K_{D,\\mathrm{M1}} + [R]}$$\nSimilarly for the K63 complex:\n$$[C_{\\mathrm{K63}}] = \\frac{[R]L_{t,\\mathrm{K63}}}{K_{D,\\mathrm{K63}} + [R]}$$\nNow substitute these expressions for $[C_{\\mathrm{M1}}]$ and $[C_{\\mathrm{K63}}]$ into the receptor mass balance equation:\n$$R_t = [R] + \\frac{[R]L_{t,\\mathrm{M1}}}{K_{D,\\mathrm{M1}} + [R]} + \\frac{[R]L_{t,\\mathrm{K63}}}{K_{D,\\mathrm{K63}} + [R]}$$\nLet $x = [R]$. We substitute the given numerical values (all in units of $\\mathrm{nM}$):\n$$200 = x + \\frac{100x}{100 + x} + \\frac{100x}{1000 + x}$$\nTo solve for $x$, we first clear the denominators by multiplying all terms by $(100 + x)(1000 + x)$:\n$$200(100 + x)(1000 + x) = x(100 + x)(1000 + x) + 100x(1000 + x) + 100x(100 + x)$$\nExpanding the products and collecting terms leads to a cubic polynomial equation for $x$:\n$$200(x^2 + 1100x + 100000) = x(x^2 + 1100x + 100000) + 100x^2 + 100000x + 100x^2 + 10000x$$\n$$200x^2 + 220000x + 20000000 = x^3 + 1100x^2 + 100000x + 200x^2 + 110000x$$\n$$0 = x^3 + (1300 - 200)x^2 + (210000 - 220000)x - 20000000$$\n$$x^3 + 1100x^2 - 10000x - 20000000 = 0$$\nThis cubic equation must be solved for $x = [R]$. The only physically valid solution is one that is real and positive. Numerical solution of this equation yields the root:\n$$x = [R] \\approx 131.5562\\,\\mathrm{nM}$$\nUsing this value for the free receptor concentration, we can now calculate the concentrations of the bound complexes:\n$$[C_{\\mathrm{M1}}] = \\frac{131.5562 \\times 100}{100 + 131.5562} = \\frac{13155.62}{231.5562} \\approx 56.8123\\,\\mathrm{nM}$$\n$$[C_{\\mathrm{K63}}] = \\frac{131.5562 \\times 100}{1000 + 131.5562} = \\frac{13155.62}{1131.5562} \\approx 11.6261\\,\\mathrm{nM}$$\nThe problem asks for the fractions of UBAN molecules bound to each ligand, which we denote $f_{\\mathrm{M1}}$ and $f_{\\mathrm{K63}}$. These are calculated as the ratio of the complex concentration to the total receptor concentration, $R_t$:\n$$f_{\\mathrm{M1}} = \\frac{[C_{\\mathrm{M1}}]}{R_t} = \\frac{56.8123\\,\\mathrm{nM}}{200\\,\\mathrm{nM}} \\approx 0.2840615$$\n$$f_{\\mathrm{K63}} = \\frac{[C_{\\mathrm{K63}}]}{R_t} = \\frac{11.6261\\,\\mathrm{nM}}{200\\,\\mathrm{nM}} \\approx 0.0581305$$\nRounding these fractions to four significant figures as required by the problem statement:\n$$f_{\\mathrm{M1}} \\approx 0.2841$$\n$$f_{\\mathrm{K63}} \\approx 0.05813$$\nThese are the final fractions of the UBAN receptor population bound to M1-linked and K63-linked tetraubiquitin, respectively.", "answer": "$$ \\boxed{\\begin{pmatrix} 0.2841 & 0.05813 \\end{pmatrix}} $$", "id": "2905232"}]}